Self-screen Revenue

Biotechnology Research • Amsterdam, North Holland, Netherlands • 11-20 Employees

Self-screen revenue & valuation

Annual revenue	$1,112,215
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,600,000
Total funding	$3,600,000

Key Contact at Self-screen

Wim Ket

Co-Owner & Advisor

Company overview

Headquarters	Amsterdam, North Holland, Netherlands
Phone number	+3134292236
Website	self-screen.nl
NAICS	541714
SIC	873
Founded	2008
Employees	11-20
Socials

Self-screen Email Formats

Self-screen uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@self-screen.nl), used 80% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@self-screen.nl	80%
{last name}.{last name}	doe.doe@self-screen.nl	20%

About Self-screen

The history of Self-screen is a track record in translational science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of cancer screening into routine practice. Our dedication is towards the development and clinical application of molecular assays for the early detection of cancer, thereby to the benefit of patients around the world. Currently, the company’s main focus is on cervical cancer screening and prevention. The company has two clinically validated assays on the market. We strive towards all-molecular screening to ensure objectivity, reproducibility and high-throughput possibilities. Our research and development pipeline currently focuses on the extension of our science towards other sample types, like urine, and towards other cancer types. HPV-Risk Assay The HPV-Risk Assay is an in vitro real-time PCR-based assay The HPV-Risk Assay is an in vitro real-time PCR-based assay for the qualitative detection of human papillomavirus (HPV) DNA, targeting the E7 region of the following 15 (probably) high-risk HPV genotypes, i.e., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, and 68. The QIAsure Methylation Test The QIAsure Methylation Test is a real-time PCR-based molecular assay The QIAsure Methylation Test is a real-time PCR-based molecular assay to distinguish women with cervical (pre)cancer. The QIAsure Methylation Test specifically detects women with a cancer-like methylation profile that have a short term high risk for progression to cervical cancer.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Senior

C-Suite

Employees by Department

Self-screen has 5 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Self-screen's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2015-08-01	9	$3,600,000

Funding Insights

$3,600,000

Total funding amount

$3,600,000

Most recent funding amount

Number of funding rounds

Self-screen Tech Stack

Discover the technologies and tools that power Self-screen's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

WP Fastest Cache

Performance

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Contact Form 7

Form builders

PHP

Programming languages

Open Graph

Miscellaneous

WordPress

Blogs

PWA

Miscellaneous

jQuery Migrate

JavaScript libraries

Bootstrap

UI frameworks

Google Analytics

Analytics

Frequently asked questions

Self-screen is located in Amsterdam, North Holland, NL.

You can reach Self-screen at +3134292236.

Self-screen generates an estimated annual revenue of $1,112,215. This revenue figure reflects the company's market position and business performance in its industry.

Self-screen has an estimated valuation of $3,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Self-screen was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.

Self-screen has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Self-screen has raised a total of $3,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Self-screen

Wim Ket

Co-Owner & Advisor

4.8

40,000 users